DOI:
10.1055/s-00000059
Pneumologie
LinksClose Window
References
Schumann C, Heigener D, Dittrich I et al.
Long term benefit from Erlotinib treatment is independent of prognostic factors and therapeutic response.
ECCO/ESMO 2009; 9146
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.